$13.15
-0.49-3.63%
Last update: Nov 10, 7:25 PM
Vir Biotechnology Inc (VIR) Stock Price, Quote, News & History
VIRNASDAQ
Vir Biotechnology reported positive Phase 3 ECLIPSE 1 data for its chronic hepatitis delta treatment ahead of planned 2027 FDA filings.
You can purchase shares of Vir Biotechnology (NASDAQ:VIR) through any online brokerage.
Other companies in Vir Biotechnology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Vir Biotechnology has a consensus price target of $29.33.
The stock price for Vir Biotechnology (NASDAQ: VIR) is $13.09 last updated November 10, 2026 at 7:25 PM EST.
There are no upcoming dividends for Vir Biotechnology.
Vir Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for Vir Biotechnology.
Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and...
